Publications by authors named "T Resasco"
Article Synopsis
- The study investigates the effects of dapagliflozin, a sodium glucose cotransporter 2 inhibitor, on cardiac changes in patients with heart failure with reduced ejection fraction (HFrEF).
- In a cohort of 300 patients, nearly half showed significant improvements in heart function metrics after 6 months of treatment, and the rate of elevated left ventricular filling pressures dropped dramatically.
- These positive changes in heart structure and function contributed to fewer hospitalizations related to heart failure and a notable decrease in natriuretic peptide levels over 12 months.
We describe the first case of acute cardiac injury directly linked to myocardial localization of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in a 69-year-old patient with flu-like symptoms rapidly degenerating into respiratory distress, hypotension, and cardiogenic shock. The patient was successfully treated with venous-arterial extracorporeal membrane oxygenation (ECMO) and mechanical ventilation. Cardiac function fully recovered in 5 days and ECMO was removed.
View Article and Find Full Text PDFObjective: To investigate the correlation between ultrasonographically evaluated intima-media thickness (IMT) of common carotid artery (CCA) and cardiovascular risk factors for subjects with newly detected, uncomplicated and untreated primary hypertension.
Methods: The study population consisted of 200 subjects (123 men and 77 women, aged 46+/-7.5 years).